|
1
|
Li P, Cheng B, Yao Y, Yu W, Liu L, Cheng S, Zhang L, Ma M, Qi X, Liang C, Chu X, Ye J, Sun S, Jia Y, Guo X, Wen Y, Zhang F. WISP1 Is Involved in the Pathogenesis of Kashin-Beck Disease via the Autophagy Pathway. Int J Mol Sci 2023; 24:16037. [PMID: 38003226 PMCID: PMC10671535 DOI: 10.3390/ijms242216037] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/03/2023] [Revised: 10/26/2023] [Accepted: 11/01/2023] [Indexed: 11/26/2023] Open
Abstract
OBJECTIVE Kashin-Beck disease (KBD) is a kind of endemic and chronic osteochondropathy in China. This study aims to explore the functional relevance and potential mechanism of Wnt-inducible signaling pathway protein 1 (WISP1) in the pathogenesis of KBD. DESIGN KBD and control cartilage specimens were collected for tissue section observation and primary chondrocyte culture. Firstly, the morphological and histopathological observations were made under a light and electron microscope. Then, the expression levels of WISP1 as well as molecular markers related to the autophagy pathway and extracellular matrix (ECM) synthesis were detected in KBD and control chondrocytes by qRT-PCR, Western blot, and immunohistochemistry. Furthermore, the lentiviral transfection technique was applied to make a WISP1 knockdown cell model based on KBD chondrocytes. In vitro intervention experiments were conducted on the C28/I2 human chondrocyte cell line using human recombinant WISP1 (rWISP1). RESULTS The results showed that the autolysosome appeared in the KBD chondrocytes. The expression of WISP1 was significantly higher in KBD chondrocytes. Additionally, T-2 toxin, a risk factor for KBD onset, could up-regulate the expression of WISP1 in C28/I2. The autophagy markers ATG4C and LC3II were upregulated after the low-concentration treatment of T-2 toxin and downregulated after the high-concentration treatment. After knocking down WISP1 expression in KBD chondrocytes, MAP1LC3B decreased while ATG4C and COL2A1 increased. Moreover, the rWISP1 protein treatment in C28/I2 chondrocytes could upregulate the expression of ATG4C and LC3II at the beginning and downregulate them then. CONCLUSIONS Our study suggested that WISP1 might play a role in the pathogenesis of KBD through autophagy.
Collapse
Affiliation(s)
- Ping Li
- Key Laboratory of Trace Elements and Endemic Disease of National Health Commission of the People’s Republic of China, School of Public Health, Health Science Center, Xi’an Jiaotong University, No. 76 Yanta West Road, Xi’an 710061, China; (P.L.); (B.C.); (Y.Y.); (L.L.); (S.C.); (L.Z.); (M.M.); (X.Q.); (C.L.); (X.C.); (J.Y.); (S.S.); (Y.J.); (X.G.)
| | - Bolun Cheng
- Key Laboratory of Trace Elements and Endemic Disease of National Health Commission of the People’s Republic of China, School of Public Health, Health Science Center, Xi’an Jiaotong University, No. 76 Yanta West Road, Xi’an 710061, China; (P.L.); (B.C.); (Y.Y.); (L.L.); (S.C.); (L.Z.); (M.M.); (X.Q.); (C.L.); (X.C.); (J.Y.); (S.S.); (Y.J.); (X.G.)
| | - Yao Yao
- Key Laboratory of Trace Elements and Endemic Disease of National Health Commission of the People’s Republic of China, School of Public Health, Health Science Center, Xi’an Jiaotong University, No. 76 Yanta West Road, Xi’an 710061, China; (P.L.); (B.C.); (Y.Y.); (L.L.); (S.C.); (L.Z.); (M.M.); (X.Q.); (C.L.); (X.C.); (J.Y.); (S.S.); (Y.J.); (X.G.)
| | - Wenxing Yu
- Department of Joint Surgery, Xi’an Honghui Hospital, Health Science Center, Xi’an Jiaotong University, Xi’an 710054, China;
| | - Li Liu
- Key Laboratory of Trace Elements and Endemic Disease of National Health Commission of the People’s Republic of China, School of Public Health, Health Science Center, Xi’an Jiaotong University, No. 76 Yanta West Road, Xi’an 710061, China; (P.L.); (B.C.); (Y.Y.); (L.L.); (S.C.); (L.Z.); (M.M.); (X.Q.); (C.L.); (X.C.); (J.Y.); (S.S.); (Y.J.); (X.G.)
| | - Shiqiang Cheng
- Key Laboratory of Trace Elements and Endemic Disease of National Health Commission of the People’s Republic of China, School of Public Health, Health Science Center, Xi’an Jiaotong University, No. 76 Yanta West Road, Xi’an 710061, China; (P.L.); (B.C.); (Y.Y.); (L.L.); (S.C.); (L.Z.); (M.M.); (X.Q.); (C.L.); (X.C.); (J.Y.); (S.S.); (Y.J.); (X.G.)
| | - Lu Zhang
- Key Laboratory of Trace Elements and Endemic Disease of National Health Commission of the People’s Republic of China, School of Public Health, Health Science Center, Xi’an Jiaotong University, No. 76 Yanta West Road, Xi’an 710061, China; (P.L.); (B.C.); (Y.Y.); (L.L.); (S.C.); (L.Z.); (M.M.); (X.Q.); (C.L.); (X.C.); (J.Y.); (S.S.); (Y.J.); (X.G.)
| | - Mei Ma
- Key Laboratory of Trace Elements and Endemic Disease of National Health Commission of the People’s Republic of China, School of Public Health, Health Science Center, Xi’an Jiaotong University, No. 76 Yanta West Road, Xi’an 710061, China; (P.L.); (B.C.); (Y.Y.); (L.L.); (S.C.); (L.Z.); (M.M.); (X.Q.); (C.L.); (X.C.); (J.Y.); (S.S.); (Y.J.); (X.G.)
| | - Xin Qi
- Key Laboratory of Trace Elements and Endemic Disease of National Health Commission of the People’s Republic of China, School of Public Health, Health Science Center, Xi’an Jiaotong University, No. 76 Yanta West Road, Xi’an 710061, China; (P.L.); (B.C.); (Y.Y.); (L.L.); (S.C.); (L.Z.); (M.M.); (X.Q.); (C.L.); (X.C.); (J.Y.); (S.S.); (Y.J.); (X.G.)
| | - Chujun Liang
- Key Laboratory of Trace Elements and Endemic Disease of National Health Commission of the People’s Republic of China, School of Public Health, Health Science Center, Xi’an Jiaotong University, No. 76 Yanta West Road, Xi’an 710061, China; (P.L.); (B.C.); (Y.Y.); (L.L.); (S.C.); (L.Z.); (M.M.); (X.Q.); (C.L.); (X.C.); (J.Y.); (S.S.); (Y.J.); (X.G.)
| | - Xiaomeng Chu
- Key Laboratory of Trace Elements and Endemic Disease of National Health Commission of the People’s Republic of China, School of Public Health, Health Science Center, Xi’an Jiaotong University, No. 76 Yanta West Road, Xi’an 710061, China; (P.L.); (B.C.); (Y.Y.); (L.L.); (S.C.); (L.Z.); (M.M.); (X.Q.); (C.L.); (X.C.); (J.Y.); (S.S.); (Y.J.); (X.G.)
| | - Jing Ye
- Key Laboratory of Trace Elements and Endemic Disease of National Health Commission of the People’s Republic of China, School of Public Health, Health Science Center, Xi’an Jiaotong University, No. 76 Yanta West Road, Xi’an 710061, China; (P.L.); (B.C.); (Y.Y.); (L.L.); (S.C.); (L.Z.); (M.M.); (X.Q.); (C.L.); (X.C.); (J.Y.); (S.S.); (Y.J.); (X.G.)
| | - Shiquan Sun
- Key Laboratory of Trace Elements and Endemic Disease of National Health Commission of the People’s Republic of China, School of Public Health, Health Science Center, Xi’an Jiaotong University, No. 76 Yanta West Road, Xi’an 710061, China; (P.L.); (B.C.); (Y.Y.); (L.L.); (S.C.); (L.Z.); (M.M.); (X.Q.); (C.L.); (X.C.); (J.Y.); (S.S.); (Y.J.); (X.G.)
| | - Yumeng Jia
- Key Laboratory of Trace Elements and Endemic Disease of National Health Commission of the People’s Republic of China, School of Public Health, Health Science Center, Xi’an Jiaotong University, No. 76 Yanta West Road, Xi’an 710061, China; (P.L.); (B.C.); (Y.Y.); (L.L.); (S.C.); (L.Z.); (M.M.); (X.Q.); (C.L.); (X.C.); (J.Y.); (S.S.); (Y.J.); (X.G.)
| | - Xiong Guo
- Key Laboratory of Trace Elements and Endemic Disease of National Health Commission of the People’s Republic of China, School of Public Health, Health Science Center, Xi’an Jiaotong University, No. 76 Yanta West Road, Xi’an 710061, China; (P.L.); (B.C.); (Y.Y.); (L.L.); (S.C.); (L.Z.); (M.M.); (X.Q.); (C.L.); (X.C.); (J.Y.); (S.S.); (Y.J.); (X.G.)
| | - Yan Wen
- Key Laboratory of Trace Elements and Endemic Disease of National Health Commission of the People’s Republic of China, School of Public Health, Health Science Center, Xi’an Jiaotong University, No. 76 Yanta West Road, Xi’an 710061, China; (P.L.); (B.C.); (Y.Y.); (L.L.); (S.C.); (L.Z.); (M.M.); (X.Q.); (C.L.); (X.C.); (J.Y.); (S.S.); (Y.J.); (X.G.)
| | - Feng Zhang
- Key Laboratory of Trace Elements and Endemic Disease of National Health Commission of the People’s Republic of China, School of Public Health, Health Science Center, Xi’an Jiaotong University, No. 76 Yanta West Road, Xi’an 710061, China; (P.L.); (B.C.); (Y.Y.); (L.L.); (S.C.); (L.Z.); (M.M.); (X.Q.); (C.L.); (X.C.); (J.Y.); (S.S.); (Y.J.); (X.G.)
| |
Collapse
|
|
2
|
de Oliveira ICV, Galvão-Moreira LV, Vilela JL, Duarte-Silva M, Aguiar-da-Silva LD, Pereira CAA, Pereira DMS, Pinheiro AJMCR, Lima-Neto LG, Fernandes ES, Cardoso CRB, Branco-de-Almeida LS. Cinnamaldehyde modulates host immunoinflammatory responses in rat ligature-induced periodontitis and peripheral blood mononuclear cell models. Int Immunopharmacol 2023; 115:109669. [PMID: 36634418 DOI: 10.1016/j.intimp.2022.109669] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/13/2022] [Revised: 12/25/2022] [Accepted: 12/29/2022] [Indexed: 01/11/2023]
Abstract
Cinnamaldehyde is a natural product with anti-inflammatory and immune-modulatory properties, known to regulate host responses to bacterial stimuli. This study aimed to investigate the effects of cinnamaldehyde on ligature-induced periodontitis in rats, and its impact on the modulation of human peripheral blood mononuclear cells (PBMC). Male Wistar rats were assigned into three groups:i) control: no ligature + vehicle; ii) ligature: ligature + vehicle; and iii) ligature + cinnamaldehyde (50 mg/kg); all treatments by daily oral gavage. After 14 days of induced periodontitis, the hemimandibles were collected for bone loss evaluation. The gingival levels of IL-1β, MMP-9 and iNOS mRNA were evaluated. Nitric oxide (NO) was measured in both rat saliva and plasma. PBMC were stimulated with Aggregatibacter actinomycetemcomitans (Aa) in the presence or absence of cinnamaldehyde (5, 20 e 40 µM), and cytokine production was quantified in cell supernatant. Proliferating lymphocytes were taken for flow cytometer reading, while culture supernatants were used for IFN-γ and IL-10 assessment. The ligature group had both increased alveolar bone loss and gingival expression of IL-1β, MMP-9 and iNOS compared to the control group. All parameters were attenuated by cinnamaldehyde treatment. Lower salivary but not plasma NO was detected in the cinnamaldehyde compared to the ligature group. Aa-stimulated PBMCs treated with cinnamaldehyde produced less IL-1β; the compound also attenuated lymphocyte proliferation in a dose-dependent manner, as well as cell IL-10 production. Cinnamaldehyde treatment reduced periodontal bone loss, and downregulated key inflammatory mediators and human PBMC responses, pointing to novel potential therapeutic effects of this compound.
Collapse
Affiliation(s)
- Izabel C V de Oliveira
- Post Graduate Program in Dentistry, Federal University of Maranhão, Av. dos Portugueses, 1966 - Bacanga, São Luís, Maranhão, Brazil
| | - Leonardo V Galvão-Moreira
- School of Medicine, Federal University of Maranhão, Av. dos Portugueses, 1966 - Bacanga, São Luís, Maranhão, Brazil
| | - Juliana L Vilela
- School of Dentistry, Federal University of Maranhão, Av. dos Portugueses, 1966 - Bacanga, São Luís, Maranhão, Brazil
| | - Murillo Duarte-Silva
- Department of Biochemistry and Immunology, School of Medicine of Ribeirão Preto, University of São Paulo, Av. Bandeirantes, 3900 - Campus da USP, Ribeirão Preto, São Paulo, Brazil
| | - Lucas D Aguiar-da-Silva
- School of Dentistry, Federal University of Maranhão, Av. dos Portugueses, 1966 - Bacanga, São Luís, Maranhão, Brazil
| | - Cesar A A Pereira
- School of Dentistry, Federal University of Maranhão, Av. dos Portugueses, 1966 - Bacanga, São Luís, Maranhão, Brazil
| | - Domingos M S Pereira
- Programa de Pós-Graduação, Universidade CEUMA, R. Anapurus, 1 - Renascença II, São Luís, Maranhão, Brazil
| | - Aruanã J M C R Pinheiro
- Programa de Pós-Graduação, Universidade CEUMA, R. Anapurus, 1 - Renascença II, São Luís, Maranhão, Brazil
| | - Lídio G Lima-Neto
- Programa de Pós-Graduação, Universidade CEUMA, R. Anapurus, 1 - Renascença II, São Luís, Maranhão, Brazil
| | - Elizabeth S Fernandes
- Programa de Pós-Graduação em Biotecnologia Aplicada à Saúde da Criança e do Adolescente, Faculdades Pequeno Príncipe, Av. Iguaçu, 333 - Curitiba, Paraná, Brazil; Instituto de Pesquisa Pelé Pequeno Príncipe, Av. Silva Jardim, 1632 - Água Verde, Curitiba, Paraná, Brazil
| | - Cristina R B Cardoso
- Department of Clinical Analysis, Toxicology and Food Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Av. do Café, s/n - Vila Monte Alegre, Ribeirão Preto, São Paulo, Brazil
| | - Luciana S Branco-de-Almeida
- Post Graduate Program in Dentistry, Federal University of Maranhão, Av. dos Portugueses, 1966 - Bacanga, São Luís, Maranhão, Brazil.
| |
Collapse
|
|
3
|
Crotty Alexander LE, Drummond CA, Hepokoski M, Mathew D, Moshensky A, Willeford A, Das S, Singh P, Yong Z, Lee JH, Vega K, Du A, Shin J, Javier C, Tian J, Brown JH, Breen EC. Chronic inhalation of e-cigarette vapor containing nicotine disrupts airway barrier function and induces systemic inflammation and multiorgan fibrosis in mice. Am J Physiol Regul Integr Comp Physiol 2018; 314:R834-R847. [PMID: 29384700 DOI: 10.1152/ajpregu.00270.2017] [Citation(s) in RCA: 144] [Impact Index Per Article: 24.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
Abstract
Electronic (e)-cigarettes theoretically may be safer than conventional tobacco. However, our prior studies demonstrated direct adverse effects of e-cigarette vapor (EV) on airway cells, including decreased viability and function. We hypothesize that repetitive, chronic inhalation of EV will diminish airway barrier function, leading to inflammatory protein release into circulation, creating a systemic inflammatory state, ultimately leading to distant organ injury and dysfunction. C57BL/6 and CD-1 mice underwent nose only EV exposure daily for 3-6 mo, followed by cardiorenal physiological testing. Primary human bronchial epithelial cells were grown at an air-liquid interface and exposed to EV for 15 min daily for 3-5 days before functional testing. Daily inhalation of EV increased circulating proinflammatory and profibrotic proteins in both C57BL/6 and CD-1 mice: the greatest increases observed were in angiopoietin-1 (31-fold) and EGF (25-fold). Proinflammatory responses were recapitulated by daily EV exposures in vitro of human airway epithelium, with EV epithelium secreting higher IL-8 in response to infection (227 vs. 37 pg/ml, respectively; P < 0.05). Chronic EV inhalation in vivo reduced renal filtration by 20% ( P = 0.017). Fibrosis, assessed by Masson's trichrome and Picrosirius red staining, was increased in EV kidneys (1.86-fold, C57BL/6; 3.2-fold, CD-1; P < 0.05), heart (2.75-fold, C57BL/6 mice; P < 0.05), and liver (1.77-fold in CD-1; P < 0.0001). Gene expression changes demonstrated profibrotic pathway activation. EV inhalation altered cardiovascular function, with decreased heart rate ( P < 0.01), and elevated blood pressure ( P = 0.016). These data demonstrate that chronic inhalation of EV may lead to increased inflammation, organ damage, and cardiorenal and hepatic disease.
Collapse
Affiliation(s)
- Laura E Crotty Alexander
- Pulmonary Critical Care Section, Department of Medicine, Veterans Affairs San Diego Healthcare System, San Diego, California.,Division of Pulmonary Critical Care and Sleep Medicine, Department of Medicine, University of California , San Diego, California
| | | | - Mark Hepokoski
- Pulmonary Critical Care Section, Department of Medicine, Veterans Affairs San Diego Healthcare System, San Diego, California.,Division of Pulmonary Critical Care and Sleep Medicine, Department of Medicine, University of California , San Diego, California
| | - Denzil Mathew
- Pulmonary Critical Care Section, Department of Medicine, Veterans Affairs San Diego Healthcare System, San Diego, California
| | - Alex Moshensky
- Pulmonary Critical Care Section, Department of Medicine, Veterans Affairs San Diego Healthcare System, San Diego, California.,Division of Pulmonary Critical Care and Sleep Medicine, Department of Medicine, University of California , San Diego, California
| | - Andrew Willeford
- Department of Pharmacology, University of California , San Diego, California
| | - Soumita Das
- Department of Pathology, University of California , San Diego, California
| | - Prabhleen Singh
- Division of Nephrology and Hypertension, Department of Medicine, University of California , San Diego, California.,Nephrology Section, Department of Medicine, Veterans Affairs San Diego Healthcare System, San Diego, California
| | - Zach Yong
- Pulmonary Critical Care Section, Department of Medicine, Veterans Affairs San Diego Healthcare System, San Diego, California.,Division of Pulmonary Critical Care and Sleep Medicine, Department of Medicine, University of California , San Diego, California
| | - Jasmine H Lee
- Division of Physiology, Department of Medicine, University of California , San Diego, California
| | - Kevin Vega
- Department of Pathology, University of California , San Diego, California
| | - Ashley Du
- Pulmonary Critical Care Section, Department of Medicine, Veterans Affairs San Diego Healthcare System, San Diego, California.,Division of Pulmonary Critical Care and Sleep Medicine, Department of Medicine, University of California , San Diego, California
| | - John Shin
- Pulmonary Critical Care Section, Department of Medicine, Veterans Affairs San Diego Healthcare System, San Diego, California.,Division of Pulmonary Critical Care and Sleep Medicine, Department of Medicine, University of California , San Diego, California
| | - Christian Javier
- Pulmonary Critical Care Section, Department of Medicine, Veterans Affairs San Diego Healthcare System, San Diego, California.,Division of Pulmonary Critical Care and Sleep Medicine, Department of Medicine, University of California , San Diego, California
| | - Jiang Tian
- Division of Cardiovascular Medicine and Center for Hypertension and Personalized Medicine, University of Toledo , Toledo, Ohio.,Department of Medicine, College of Medicine and Life Sciences, University of Toledo , Toledo, Ohio
| | - Joan Heller Brown
- Department of Pharmacology, University of California , San Diego, California
| | - Ellen C Breen
- Division of Physiology, Department of Medicine, University of California , San Diego, California
| |
Collapse
|